Clinical trials research potential new treatments for people living with MS. Nearly 1 million people in the U.S. have been diagnosed with MS. Symptoms vary from person to person, but most commonly include fatigue and difficulty walking. Relapsing-remitting MS (RRMS) is the most common disease course – approximately 85% of people with MS are first diagnosed with this type.
https://antidote.me/prescreener/g/relapsing-remitting-multiple-sclerosis-975-1?utm_source=msvn_org&utm_medium=referral&utm_campaign=TMRRMS975
https://antidote.me/prescreener/g/relapsing-remitting-multiple-sclerosis-975-1?utm_source=msvn_org&utm_medium=referral&utm_campaign=TMRRMS975